J&J ordered to pay $327 mln over marketing of drug (Reuters)
NEW YORK, June 3 (Reuters) - A unit of Johnson & Johnson was ordered on Friday to pay $327 million in civil penalties to the state of South Carolina over the marketing of its antipsychotic drug Risperdal.
No comments:
Post a Comment